# Safety and Tolerability Study of 68Ga/177Lu-BRP-020063 in Advanced Solid Tumors

> **NCT07439120** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine** · enrollment: 10 (estimated)

## Conditions studied

- Urothelial Carcinoma (UC)

## Interventions

- **DRUG:** ⁶⁸Ga/¹⁷⁷Lu-BRP-020063

## Key facts

- **NCT ID:** NCT07439120
- **Lead sponsor:** Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-02
- **Primary completion:** 2026-08-31
- **Final completion:** 2026-08-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07439120

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07439120, "Safety and Tolerability Study of 68Ga/177Lu-BRP-020063 in Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07439120. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*